This review article focuses on lipoprotein transport-dependent and -independent mechanisms by which apoE deficiency or polymorphisms contribute to cardiovascular disease, metabolic disease, and neurological disorders. This evidence concerns the gene APOE and hyperinsulinemic hypoglycemia, familial, 4.